Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 46,296,328
  • Shares Outstanding, K 580,300
  • Annual Sales, $ 6,068 M
  • Annual Income, $ 1,074 M
  • EBIT $ 1,264 M
  • EBITDA $ 1,419 M
  • 60-Month Beta 0.94
  • Price/Sales 7.55
  • Price/Cash Flow 28.93
  • Price/Book 4.54

Options Overview Details

View History
  • Implied Volatility 27.66% (+0.47%)
  • Historical Volatility 26.02%
  • IV Percentile 58%
  • IV Rank 28.03%
  • IV High 52.16% on 04/08/25
  • IV Low 18.11% on 08/28/25
  • Expected Move (DTE 27) 4.07 (5.10%)
  • Put/Call Vol Ratio 0.13
  • Today's Volume 1,895
  • Volume Avg (30-Day) 2,562
  • Put/Call OI Ratio 1.85
  • Today's Open Interest 78,392
  • Open Int (30-Day) 66,937
  • Expected Range 75.71 to 83.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 31 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.72
  • Number of Estimates 11
  • High Estimate 0.73
  • Low Estimate 0.71
  • Prior Year 0.64
  • Growth Rate Est. (year over year) +12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
74.66 +6.86%
on 02/11/26
86.19 -7.44%
on 01/22/26
-3.68 (-4.41%)
since 01/20/26
3-Month
74.66 +6.86%
on 02/11/26
87.89 -9.23%
on 12/05/25
-4.31 (-5.13%)
since 11/20/25
52-Week
65.94 +20.99%
on 04/09/25
87.89 -9.23%
on 12/05/25
+5.07 (+6.79%)
since 02/20/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair...

See More

Key Turning Points

3rd Resistance Point 82.40
2nd Resistance Point 81.17
1st Resistance Point 80.47
Last Price 79.78
1st Support Level 78.54
2nd Support Level 77.31
3rd Support Level 76.61

See More

52-Week High 87.89
Last Price 79.78
Fibonacci 61.8% 79.51
Fibonacci 50% 76.92
Fibonacci 38.2% 74.32
52-Week Low 65.94

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar